These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31593656)

  • 21. What is the radiological definition of part-solid tumour in lung cancer?†.
    Matsunaga T; Suzuki K; Takamochi K; Oh S
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):242-247. PubMed ID: 28119328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer.
    Shewale JB; Nelson DB; Rice DC; Sepesi B; Hofstetter WL; Mehran RJ; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Antonoff MB
    Ann Thorac Surg; 2018 Jun; 105(6):1671-1677. PubMed ID: 29432718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Influence of Clinical T Factor on Predicting Pathologic N Factor in Resected Lung Cancer.
    Shimamatsu S; Takenoyama M; Shimokawa M; Takada K; Edagawa M; Toyozawa R; Nosaki K; Oba T; Tagawa T; Yamaguchi M; Taguchi K; Seto T
    Ann Thorac Surg; 2019 Oct; 108(4):1080-1086. PubMed ID: 31103386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.
    Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM
    Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer with Radiologic Part-Solid or Solid Lesions.
    Fu F; Zhang Y; Wen Z; Zheng D; Gao Z; Han H; Deng L; Wang S; Liu Q; Li Y; Shen L; Shen X; Zhao Y; Zhao Z; Ye T; Xiang J; Zhang Y; Sun Y; Hu H; Chen H
    J Thorac Oncol; 2019 Dec; 14(12):2133-2142. PubMed ID: 31437531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Proposal for Restaging of Invasive Lung Adenocarcinoma Manifesting as Pure Ground Glass Opacity.
    Mao R; She Y; Zhu E; Chen D; Dai C; Wu C; Xie H; Zhu H; Fei K; Chen C
    Ann Thorac Surg; 2019 May; 107(5):1523-1531. PubMed ID: 30576635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma.
    Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M
    Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Nodule Density in Women With Sublobar Resection for Stage IA Adenocarcinoma.
    Phillips WW; Gill RR; Mazzola E; Armitage JR; de Forcrand C; Colson YL; Gibney BC
    Ann Thorac Surg; 2021 Oct; 112(4):1067-1075. PubMed ID: 33181131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.
    Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Aokage K; Saji H; Watanabe SI;
    J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1469-1480. PubMed ID: 32451073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
    Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
    Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome of resected solid-type small-sized c-stage IA non-small cell lung cancer.
    Inoue M; Minami M; Sawabata N; Utsumi T; Kadota Y; Shigemura N; Okumura M
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1445-9. PubMed ID: 20137967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis of unexpected and expected pathologic N1 non-small cell lung cancer.
    Shin S; Kim HK; Choi YS; Kim K; Kim J; Shim YM
    Ann Thorac Surg; 2013 Sep; 96(3):969-75; discussion 975-6. PubMed ID: 23916803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Features of Ground Glass Opacity-Dominant Lung Cancer Exceeding 3.0 cm in the Whole Tumor Size.
    Suzuki S; Sakurai H; Yotsukura M; Masai K; Asakura K; Nakagawa K; Motoi N; Watanabe SI
    Ann Thorac Surg; 2018 May; 105(5):1499-1506. PubMed ID: 29427615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung cancer with scattered consolidation: detection of new independent radiological category of peripheral lung cancer on thin-section computed tomography.
    Matsunaga T; Suzuki K; Hattori A; Fukui M; Kitamura Y; Miyasaka Y; Takamochi K; Oh S
    Interact Cardiovasc Thorac Surg; 2013 Apr; 16(4):445-9. PubMed ID: 23248167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ground-glass opacity lesions on computed tomography during postoperative surveillance for primary non-small cell lung cancer.
    Haro A; Yano T; Kohno M; Yoshida T; Okamoto T; Maehara Y
    Lung Cancer; 2012 Apr; 76(1):56-60. PubMed ID: 21945659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma.
    Murakawa T; Konoeda C; Ito T; Inoue Y; Sano A; Nagayama K; Nakajima J
    Eur J Cardiothorac Surg; 2013 May; 43(5):925-32. PubMed ID: 23047267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic features and computed tomographic findings of 52 surgically resected adenosquamous carcinomas of the lung.
    Watanabe Y; Tsuta K; Kusumoto M; Yoshida A; Suzuki K; Asamura H; Tsuda H
    Ann Thorac Surg; 2014 Jan; 97(1):245-51. PubMed ID: 24206962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
    Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
    Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.